These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


421 related items for PubMed ID: 7827266

  • 21. Ninhydrin as a reversible protecting group of amino-terminal cysteine.
    Pool CT, Boyd JG, Tam JP.
    J Pept Res; 2004 Mar; 63(3):223-34. PubMed ID: 15049834
    [Abstract] [Full Text] [Related]

  • 22. The first total synthesis of the peptaibol hypomurocin A1 and its conformation analysis: an application of the 'azirine/oxazolone method'.
    Pradeille N, Zerbe O, Möhle K, Linden A, Heimgartner H.
    Chem Biodivers; 2005 Sep; 2(9):1127-52. PubMed ID: 17193196
    [Abstract] [Full Text] [Related]

  • 23. Fmoc-based synthesis of disulfide-rich cyclic peptides.
    Cheneval O, Schroeder CI, Durek T, Walsh P, Huang YH, Liras S, Price DA, Craik DJ.
    J Org Chem; 2014 Jun 20; 79(12):5538-44. PubMed ID: 24918986
    [Abstract] [Full Text] [Related]

  • 24. Influence of solid support, solvent and coupling reagent on the head-to-tail cyclization of resin-bound peptides.
    McMurray JS, Lewis CA, Obeyesekere NU.
    Pept Res; 1994 Jun 20; 7(4):195-206. PubMed ID: 7696839
    [Abstract] [Full Text] [Related]

  • 25. Synthesis, DNA binding, and sequence specificity of DNA alkylation by some novel cyclic peptide-chlorambucil conjugates.
    Sheh L, Chang HW, Ong CW, Chen SL, Bailly C, Linssen RC, Waring MJ.
    Anticancer Drug Des; 1995 Jul 20; 10(5):373-88. PubMed ID: 7639928
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Solid-phase functionalization of peptides by an alpha-hydrazinoacetyl group.
    Bonnet D, Grandjean C, Rousselot-Pailley P, Joly P, Bourel-Bonnet L, Santraine V, Gras-Masse H, Melnyk O.
    J Org Chem; 2003 Sep 05; 68(18):7033-40. PubMed ID: 12946145
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Thiocarbamate-linked peptides by chemoselective peptide ligation.
    Besret S, Ollivier N, Blanpain A, Melnyk O.
    J Pept Sci; 2008 Dec 05; 14(12):1244-50. PubMed ID: 18752254
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pentaerythrityltetramine scaffolds for solid-phase combinatorial chemistry.
    Virta P, Leppänen M, Lönnberg H.
    J Org Chem; 2004 Mar 19; 69(6):2008-16. PubMed ID: 15058947
    [Abstract] [Full Text] [Related]

  • 34. [Synthesis, 13C-NMR and CD study of the N-terminal tridecapeptide sequence of human fibroblast interferon].
    Jung G, Brückner H.
    Hoppe Seylers Z Physiol Chem; 1981 Mar 19; 362(3):275-89. PubMed ID: 6164623
    [Abstract] [Full Text] [Related]

  • 35. [Fmoc solid-phase synthesis of cyclopeptide FIK].
    Zhang J, Shi W, Chen W.
    Sheng Wu Gong Cheng Xue Bao; 2008 Mar 19; 24(3):468-72. PubMed ID: 18589824
    [Abstract] [Full Text] [Related]

  • 36. Limiting racemization and aspartimide formation in microwave-enhanced Fmoc solid phase peptide synthesis.
    Palasek SA, Cox ZJ, Collins JM.
    J Pept Sci; 2007 Mar 19; 13(3):143-8. PubMed ID: 17121420
    [Abstract] [Full Text] [Related]

  • 37. p-Nitrobenzyl side-chain protection for solid-phase synthesis.
    Hocker MD, Caldwell CG, Macsata RW, Lyttle MH.
    Pept Res; 1995 Mar 19; 8(6):310-15. PubMed ID: 8838413
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Synthesis and 13C-NMR spectra of the N-terminal decapeptide sequence of human lymphoblast interferon].
    Jung G, Brückner H.
    Hoppe Seylers Z Physiol Chem; 1981 Mar 19; 362(3):291-304. PubMed ID: 6164624
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 22.